AtriCure reports solid 4Q revenue growth

Cardiac medical device maker AtriCure today announced preliminary financial results for fourth quarter and full year 2012.

Preliminary revenue for the fourth quarter of 2012 is expected to be approximately $18.4 million, about 9.5% more than fourth quarter 2011. Preliminary revenue for full year 2012 is expected to be $70.2 million, reflecting year-over-year growth of 9.1%.

West Chester-based AtriCure manufactures and markets cardiac surgical ablation systems designed to treat atrial fibrillation (AF) and systems for the exclusion of the left atrial appendage. The company brought on Mike Carrel as president and CEO AtriCure in November.

“In my first two months at AtriCure, I have spent considerable time evaluating the strategic and operational aspects of the company through in depth conversations with employees, clinical partners, customers, and shareholders,” Carrel said. “I have found many strengths—we have truly differentiated technology, solid customer relationships, an unparalleled training program, and a talented and committed group of employees.

Read AtriCure’s full news release here.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

IBM and Cleveland Clinic use Watson to advance genomic research for cancer care pilot | PR Newswire, October 29, 2014

Cleveland Clinic announces Top Ten medical innovations for 2015, mobile stroke unit and Dengue vaccine top list (video) | Cleveland.com, October 29, 2014

Scientific breakthrough at Cincinnati Children’s Hospital Medical Center could help battle cancer, ulcers | Cincinnati Business Courier, October 29, 2014

Researchers at Cincinnati Children’s Hospital Medical Center studying how to create replacement organs for people who need transplants | Cincinnati Business Courier, October 28, 2014

Juventas Therapeutics strengthens management team with new senior vice president of finance and operations, Troy Ignelzi | PR Newswire, October 28, 2014

Enable Injections signs strategic development agreement with CSL Behring to market novel drug delivery device | Philadelphia Business Journal, October 28, 2014

Ohio Soybean Council Foundation offers $36,000 in scholarships, majors include biotechnology | Ohio Soybean Council Foundation, October 28, 2014

Danaher’s Leica Biosystems division agrees to buy Devicor Medical Products, a developer of breast biopsy products | MASS Device, October 28, 2014

Local innovators in the spotlight at Cleveland Clinic Medical Innovation Summit | Fresh Water Cleveland, October 27, 2014

BioKansas to celebrate 10 year anniversary and tenure of retiring President and CEO Angela Kreps | BioKansas, October 24, 2014

Patients & Consumers Pharma receives $500k from Dayton’s Accelerant Fund | Dayton Business Journal, October 24, 2014

Cleveland Clinic Medical Innovation Summit opens Sunday with a focus on personalized cancer treatments | Cleveland.com, October 23, 2014

Philips Healthcare resumes medical imaging manufacturing in Highland Heights | Crains Cleveland, October 23, 2014

HealthSpot wins telemedicine fans in Cleveland, but Nationwide Children’s presses pause | Columbus Business First, October 23, 2014

Advanced BioSensors-Ohio and Real Time Imaging Technologies finalists in PtotoTech pitch contest | Fresh Water Cleveland, October 22, 2014

NuVasive Manufacturing in Fairborn adding 35 positions, double production during the next three to five years | Dayton Business Journal, October 22, 2014

STERIS relocating global specialty services HQ to Birmingham, AL, hiring 200 | Birmingham Business Journal, October 22, 2014

Porter Wright getting new managing partner, Bob Tannous will take over for Robert Trafford | Columbus Business First, October 22, 2014

Contract sterilization company Sterigenics may be up for sale | Reuters, October 22, 2014

Cardinal Health donates one million medical products to help fight Ebola in West Africa | The Columbus Dispatch, October 21, 2014